Virtua's $500 million project includes construction of a new six-story patient pavilion, named in honor of philanthropist ...

Had it been up to Jenna Ortega, she would have spent the summer after Wednesday’s debut season chilling on an Icelandic ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the William Blair ...

Imperial College, London, one of the top universities in the world with QS global ranking number 2, launched its Imperial ...

DUBLIN– (BUSINESS WIRE)– ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how ...

BURLINGAME, CA, UNITED STATES, May 16, 2025 /EINPresswire.com/ -- The global pharmaceutical contract sales outsourcing (CSO) ...

The Los Angeles County Sheriff’s Department said Thursday that it has opened a criminal investigation into rape and sexual assault allegations against. Coinbase said cyber crooks stole customer ...

ICON Public Limited Company (NASDAQ:ICLR), a Contract Research Organization (CRO), is a healthcare intelligence and clinical research firm. The company offers services to pharmaceutical companies that ...

Icon’s smaller biotechnology customers were also affected by the “unfavourable funding environment”, which limited their ability to hire clinical research organisations (CROs) to run drug ...

In July 2024, IntegriChain, a data-driven pharmaceutical consulting and outsourcing platform declared the acquisition of Federakl Compliance Solutions which is a leading Pharma advisory and managed ...

Special Counsel Says ICON CEO Steve Cutler says trial activity has been “impacted by cautious spending from biopharma customers in both the biotech and large pharma businesses.” The company ...

"ICON Public Limited Company (NASDAQ:ICLR): The stock pulled back on news that biotechnology funding has dropped, albeit from very strong growth levels. We continue to believe the company is a ...